Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Starton Therapeutics Inc. See All Filings	D	2024-10-22 15:02:31 UTC
Amount To Be Raised $2,126,035 Associated Brokers / Dealers N/A CIK Number 0001743192 Filed Document 0001743192-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-10-22 15:02:31 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Starton Therapeutics Inc. See All Filings	D	2023-10-13 16:11:49 UTC
Amount To Be Raised $970,930 Associated Brokers / Dealers N/A CIK Number 0001743192 Filed Document 0001743192-23-000003 Exclusions or Exemptions 506b Accepted Date 2023-10-13 16:11:49 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Starton Therapeutics Inc. See All Filings	D	2023-04-13 13:15:12 UTC
Amount To Be Raised $1,443,520 Associated Brokers / Dealers N/A CIK Number 0001743192 Filed Document 0001743192-23-000002 Exclusions or Exemptions 506b Accepted Date 2023-04-13 13:15:12 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Starton Therapeutics Inc. See All Filings	D	2023-01-25 12:40:51 UTC
Amount To Be Raised $1,023,417 Associated Brokers / Dealers N/A CIK Number 0001743192 Filed Document 0001743192-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-01-25 12:40:51 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Starton Therapeutics Inc. See All Filings	D	2022-02-16 14:17:34 UTC
Amount To Be Raised $1,145,350 Associated Brokers / Dealers N/A CIK Number 0001743192 Filed Document 0001743192-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-02-16 14:17:34 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Starton Therapeutics Inc. See All Filings	D	2021-11-19 20:12:26 UTC
Amount To Be Raised $1,145,375 Associated Brokers / Dealers N/A CIK Number 0001743192 Filed Document 0001743192-21-000004 Exclusions or Exemptions 506b Accepted Date 2021-11-19 20:12:26 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Starton Therapeutics Inc. See All Filings	D	2021-05-26 13:59:28 UTC
Amount To Be Raised $77,597 Associated Brokers / Dealers N/A CIK Number 0001743192 Filed Document 0001743192-21-000003 Exclusions or Exemptions 506b Accepted Date 2021-05-26 13:59:28 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
ChemioCare Inc. See All Filings	D	2020-01-13 15:00:41 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001743192 Filed Document 0001743192-20-000003 Exclusions or Exemptions 506b Accepted Date 2020-01-13 15:00:41 UTC Type of Offering D Industry Other Health Care Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
ChemioCare Inc. See All Filings	D	2018-07-02 12:11:28 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001743192 Filed Document 0001743192-18-000002 Exclusions or Exemptions 506b Accepted Date 2018-07-02 12:11:28 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity